📰 Iagnostics News
Page 82 - Iagnostics News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Iagnostics. Real-time updates on events, politics, business and more.
June 8, 2022
This study compares different modalities of diagnosis of CNS-TB.
June 8, 2022
- Clinical utility of 18F-fluciclovine being investigated in expanded areas of cancer imaging - Blue Earth Diagnostics, a Bracco company and recognized leader in the development and commercialization
June 7, 2022
Researchers evaluate the accuracy of using dogs to smell and identify the presence of SARS-CoV-2 in infected and non-infected individuals.
June 7, 2022
The primary causes of liver cancer are well known: viral (hepatitis B and C), alcohol and non-alcoholic steatohepatitis (NASH), a condition in which fat builds up in the liver, resulting in chronic inflammation and damage.
June 7, 2022
Dublin, June 07, 2022 (GLOBE NEWSWIRE) -- The "Global Cancer Diagnostics Market, By Test, Technology, Application, End User, & By Region - Forecast...
June 6, 2022
In a recent study posted to the Journal of Biochemical and Molecular Toxicology, researchers reviewed clustered regularly interspaced short palindromic repeats (CRISPR)-based diagnostics for detecting severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
June 5, 2022
Global life science industry critical materials supplier Biosynth Carbosynth has acquired Aalto Bio Reagents (Dublin), a leading developer and provider of biological materials to the in-vitro diagnostic (IVD) and vaccine development industry in the field of emerging disease. Click to read more...
June 3, 2022
Discover the latest tools and techniques to expand your research capacity with expert-led presentations
June 2, 2022
Unless you are an identical twin, you probably aren't often mistaken for someone else. Likewise, our own sense of self as distinct from all other humans is deeply ingrained since early childhood.
June 2, 2022
Researchers from the Icahn School of Medicine at Mount Sinai have applied a novel stem cell model to map disease risk variants in human neurons, which could help provide insights into the biological mechanisms that underlie neuropsychiatric disorders such as autism and schizophrenia.